ALFA Finder| Management target | Revenue 20.0% 3 years |
|---|
| Revenue growth | 16% YoY consolidated growth. |
|---|---|
| Margins | EBITDA margin improved to 15% from 12% YoY. |
| Demand visibility | Strong domestic and global demand helping efficient capacity utilization. |
| Management confidence | High, citing capacity utilization of new BOPP line within one month. |
Growth
Consolidated Net Sales grew 16% YoY to ₹800 Cr; PAT increased 39% YoY to ₹43 Cr.
Outlook
New BOPP line adds 45% capacity; target 20% CAGR topline growth over next 3 years with ₹1180 Cr capex.
Risks
Exposure to commodity price fluctuations in BOPP/BOPET markets and competitive intensity in flexible packaging.
Last quarter's promises, checked
Delivered
- Guided 15-20% US volume growth → delivered 19% overall volume growth (= BEAT)
- Guided Specialty Chemicals traction → delivered ₹204 Cr FY26 revenue (= BEAT)
- Guided CAPEX completion → delivered ₹1,200 Cr strategic spend cycle finished (= BEAT)
Partly delivered
- Guided Net Debt reduction → delivered 2.7x Net Debt/EBITDA (still above <2x target) (= PARTIAL)
- Guided Zigly/Plastech PBT positive → delivered EBITDA breakeven only (= PARTIAL)
Missed
- Guided double-digit topline growth → delivered 16% (within range but lower than previous 37% Q4 peak) (= MISS)
Earnings Call Transcript filed with NSE, NSE: COSMOFIRST. Summary written with AI assistance from the document.
Cosmo First Ltd: key numbers
- Share price
- ₹814.60
- Market cap
- ₹2,138 Cr
- Revenue (annual)
- ₹3,639 Cr
- Net profit (annual)
- ₹156.0 Cr
- P/E (TTM)
- 9.8×Sector 46.8×
- Promoter holding
- 40.78%+0.00% QoQ
- FII holding
- 3.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cosmo First Ltd
All →Cosmo First Earnings Call Transcript: Key Takeaways
Consolidated revenue ₹1,388 Cr (+51% YoY) on 15% volume; EBITDA ₹177 Cr (+38%) includes ~₹18 Cr net one-offs, normalized +24%.
Cosmo First Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹1,388 Cr (+51% YoY), EBITDA ₹177 Cr (12.8% margin), PAT ₹99 Cr (+111%, tax-aided). Net debt/EBITDA down to 1.9x from 3.0x; specialty mix improving.
Cosmo First Results Update
Cosmo First released Q2 FY27 consolidated results via press release, showing EBITDA and PAT growth. Net debt was reduced while B2B and consumer businesses scaled up.
Cosmo First Q2 FY27 Results: Net Profit ₹98.6 Cr, Up 111.1% YoY
Cosmo First Ltd reported revenue from operations of ₹1,388 Cr (+51.0% YoY) and net profit of ₹98.6 Cr (+111.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹98.6 Cr · +111.1% YoY
Cosmo First Board Meeting Date
COSMO FIRST Limited will hold a board meeting on 03-Nov-2026 to consider unaudited standalone and consolidated results for the quarter ended September 2026. Trading window closes from 01-Oct-2026 until 48 hours after results are published.
Cosmo First Acquisition Worth ₹6.1 Cr
Cosmo First Limited is acquiring Prolife Speciality Vet Clinic LLP for a cash consideration of ₹6.10 Crore to expand its Petcare division, Zigly.
- Value
- ₹6.10 Cr